Kura Oncology Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Federica Lussana. I'm part of the healthcare investment banking team at JPMorgan. It is my pleasure to introduce you to our next presenting company, Kura Oncology. The speaker is Troy Wilson, President and Chief Executive Officer.
As a kind reminder, after this session, we have a breakout session in room Sussex. Thank you, everybody.
Good morning, and thank you for the introduction. I am Troy Wilson. I'm the President and Chief Executive Officer of Kura Oncology. And I'd like to start by thanking JPMorgan for the gracious invitation to let us attend the conference and give you an update on the progress that we've been making at the company.
Just to start off, I'll just refer you to our forward-looking statement and our filings, both on our website and on the SEC's website, for additional information about Kura. So Kura is really capitalizing on the advances in the discovery
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |